Global psoriasis care patterns and outcomes (observational)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

GHSP is an international, multicenter observational study led by the University of Zurich to understand how people with psoriasis access care, what treatments they receive, how severe their disease is, and how it affects daily life. It uses both past and current medical records to compare patterns across settings from January 2020 onward. Data are collected from routine clinical care to identify disparities in care delivery and outcomes. Participation requires informed consent and a confirmed psoriasis diagnosis, with no study-specific intervention involved.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Signed General Consent Form, or equivalent document
* Confirmed diagnosis of Psoriasis

Exclusion Criteria:

* Inability to provide informed consent.
* Datasets with ambiguous or unclear diagnosis.

Where it's running

• University of Zurich
  Zurich, Switzerland Recruiting

Study contacts

• Principal investigator: Julia-Tatjana Maul, Prof. Dr. med. — University of Zurich
• Study coordinator: Julia-Tatjana Maul, Prof. Dr. med.
• Email: julia-tatjana.maul@uzh.ch
• Phone: +41 76 441 51 09

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Retinal Vessel Density and Foveal Avascular Zone Size in Psoriatic Arthritis

  This study tests whether retinal blood vessel density and the size of the foveal avascular zone differ between people with psoriatic arthritis, people with psoriasis, and healthy individuals using non-invasive eye imaging.

  Recruiting Bursa Yuksek Ihtisas Training and Research Hospital · Bursa, Yıldırım · NCT07858591

• Is XJH05 Ointment Effective for Plaque Psoriasis?

  This study tests whether the XJH05 ointment can help people with plaque psoriasis compare to a calcipotriol ointment.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07780929

• HL40626S tablets in healthy adults: a first-in-human dose study

  This Phase 1 study tests HL40626S tablets in healthy adults to see if it is safe, tolerated, and how it behaves in the body after single and 14-day multiple doses.

  Recruiting Phase 1 HighsLab Therapeutics Inc. · Melbourne, Victoria and 1 other locations · NCT07736586

• S-4321 in adults with autoimmune or immune-mediated diseases

  This study tests S-4321 in adults with autoimmune conditions to see if it is safe and tolerable and to gather early data on how the drug behaves in the body and its initial effects on disease markers.

  Recruiting at 2 sites Phase 1 Seismic Therapeutic AU Pty Ltd · Charlestown, New South Wales and 1 other locations · NCT07455578

• Semaglutide plus topical steroid/calcipotriol for plaque psoriasis in adults with overweight, obesity, or type 2 diabetes

  This trial will test whether taking oral semaglutide along with a topical steroid/calcipotriol cream improves skin symptoms and reduces metabolic inflammation in adults with plaque psoriasis who are overweight, obese, or have type 2 diabetes.

  Recruiting Phase 4 Hospital Universitario Dr. Jose E. Gonzalez · Monterrey, N.L. · NCT07401992

• Audio-based therapy to help anxiety in people with psoriasis

  This study tests whether a short audio therapy session can ease anxiety in adults with psoriasis.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07390487

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.